Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
6(46%)
Results Posted
67%(4 trials)

Phase Distribution

Ph phase_2
4
31%
Ph phase_3
1
8%
Ph phase_1
4
31%
Ph not_applicable
4
31%

Phase Distribution

4

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
4(30.8%)
Phase 2Efficacy & side effects
4(30.8%)
Phase 3Large-scale testing
1(7.7%)
N/ANon-phased studies
4(30.8%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

6

trials recruiting

Total Trials

13

all time

Status Distribution
Active(6)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Recruiting5
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
6
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (30.8%)
Phase 24 (30.8%)
Phase 31 (7.7%)
N/A4 (30.8%)

Trials by Status

completed646%
active_not_recruiting18%
withdrawn18%
recruiting538%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT06944522Phase 3

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Recruiting
NCT07318714Phase 1

A Study of ASP2246 for People Who Have Movement Problems Caused by Brain Injury After a Stroke

Recruiting
NCT06683365Phase 1

Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies

Recruiting
NCT06082349Not Applicable

The N-LVA Study: RCT Comparing LVA vs. Sham Surgery in Cancer-related Lymphedema

Recruiting
NCT07050992Not Applicable

Laser Posterior Nasal Nerve Neurolysis

Active Not Recruiting
NCT05603312Phase 1

A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants

Completed
NCT00400634Phase 2

Double-Blind, Multicenter, Sham Surgery Controlled Study of CERE-120 in Subjects With Idiopathic Parkinson's Disease

Completed
NCT04645511Not Applicable

Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis.

Recruiting
NCT02448641Phase 2

Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke

Completed
NCT00985517Phase 1

Safety and Efficacy of CERE-120 in Subjects With Parkinson's Disease

Completed
NCT02683629Phase 2

Investigation of the Safety and Efficacy of NTCELL® [Immunoprotected (Alginate-Encapsulated) Porcine Choroid Plexus Cells for Xenotransplantation] in Patients With Parkinson's Disease

Completed
NCT03347955Not Applicable

Double-blind Placebo Surgery Trial for Treatment of Parkinson's Disease

Completed
NCT02563782Phase 2

Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD

Withdrawn

All 13 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
13